GTC Biotherapeutics (fka GTCB)

[keitern]

>>wanting a partnership<<

OK, if you insist on seeing it that way. I don't think you have any evidence on which to base that. I hope you are right. It looks to me like they wanted GTCB to co-develop this drug but would have been perfectly fine with GTCB coughing up their own 25M in cash to do it. There is something troubling about a business deal where a company has to liquidate 30% of its assets before it can participate. It's not that it isn't done, just that it isn't a position of strength.

>>the company is more likley to buy more shares <<
Sadly, yes. Look at where this 25M is headed; right back into the LFB project. I hope not, but they could end up shoving more dollars through GTCB into this project before it is over, I have no idea how much it will take. I hope the 25M is enough to fund GTCB's portion to completion though, I really do. In fact, I would be thrilled if they only need half of it and the rest was GTCB's to invest in their other programs.